CHARLOTTE, NC--(Marketwire - April 07, 2008) - BurnsAdler Pharmaceuticals, Inc. (“BurnsAdler”) announced today that Collatamp™ EG has received marketing approval from ANVISA - National Agency for Surveillance in Brazil. Collatamp™ EG is a fully resorbable Gentamicin-impregnated Collagen Sponge, used as a surgical implant for local haemostasis of capillary, parenchymatous and seeping hemorrhages in areas with a high risk of infection. BurnsAdler will be co-marketing Collatamp™ EG with its local partner Meizler Biopharma, S.A. (“Meizler”).
